Clinical Trial Update: DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections [NA]

View source ↗

Summary

This completed clinical trial (NCT05509413) evaluates DEFLAGYN Vaginal Gel for cervical dysplasia and HPV infection, reporting observations of spontaneous remis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervix Dysplasia
• Hpv Infection

Drugs mentioned

• DEFLAGYN Vaginal Gel

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Cervix Dysplasia, HPV Infection | NA | Status: COMPLETED